Prof. Robert Sutton to deliver plenary presentation on Phase 2b CARPO trial of AuxoraTM in Acute Pancreatitis (AP) at American Pancreatic Association (APA) 2024 Annual Meeting Poster presentation on Phase 2b CARPO trial at Emergencies in Medicine (EIM) 2024 Meeting LA JOLLA, Calif. , Nov.
20, 2024 /PRNewswire/ -- CalciMedica Inc. ("CalciMedica") (Nasdaq: CALC ), a clinical-stage biopharmaceutical company focused on developing novel calcium release-activated calcium (CRAC) channel inhibition therapies for acute and chronic inflammatory and immunologic illnesses, today announced the acceptance of an abstract for plenary presentation at the American Pancreatic Association (APA) 2024 Annual Meeting being held December 9-10 in Maui, HI , and the acceptance of an abstract for poster presentation at the Emergencies in Medicine (EIM) 2024 Meeting being held December 8-13 in Maui, HI . Details for the presentations are as follows: Plenary Presentation at APA 2024 Annual Meeting Presentation Title: Auxora Decreases the Development of Severe Organ Failure in Patients with Acute Pancreatitis and SIRS Presenter: Prof.
Robert Sutton , B.A. (Hons), M.
B., B.S.
, D.Phil., FRCS, University of Liverpool and Liverpool University Hospitals NHS Foundation Trust Session Title: Abstract Session 2 – Pancreatitis Session Date and Time: Tuesday, December 10 , 8:00-9:30 a.
m. HST Poster Presentation at EIM 2024 Meeting Presentation Title: A Randomized, Double-Blind, Placebo Controlled Dose Ranging Study.